Early Intervention in COVID-19: Favipiravir Verses Standard Care

PHASE3CompletedINTERVENTIONAL
Enrollment

502

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

June 25, 2021

Study Completion Date

June 25, 2021

Conditions
Coronavirus Infection
Interventions
DRUG

Favipiravir

Anti-viral

OTHER

Standard of care management

Standard of care management for COVID-19

Trial Locations (6)

Unknown

Grupo Hospitalar Conceição, Porto Alegre

Fundação Oswaldo Cruz - Instituto Nacional de Infectologia Evandro Chagas (Fiocruz/INI), Rio de Janeiro

Instituto Nacional de Ciencias Medicas y Nutricion, Salvador Zubiran, Mexico City

Hull University Teaching Hospitals NHS Trust - Castle Hill Hospital, Hull

Chelsea and Westminster Hospital, London

West Middlesex University Hospital, London

All Listed Sponsors
collaborator

NEAT ID Foundation

OTHER

collaborator

FUJIFILM Toyama Chemical Co., Ltd.

INDUSTRY

collaborator

Imperial College London

OTHER

lead

Chelsea and Westminster NHS Foundation Trust

OTHER

NCT04373733 - Early Intervention in COVID-19: Favipiravir Verses Standard Care | Biotech Hunter | Biotech Hunter